Immunomedics Inc. (IMMU)

14.80
1.02 6.47
NASDAQ : Health Technology
Prev Close 15.83
Open 15.87
Day Low/High 14.74 / 16.00
52 Wk Low/High 11.55 / 27.33
Volume 1.20M
Avg Volume 2.59M
Exchange NASDAQ
Shares Outstanding 191.54M
Market Cap 2.99B
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Revance Therapeutics Soars on Phase 3 Data -- Biotech Movers

Revance Therapeutics Soars on Phase 3 Data -- Biotech Movers

The Newark, Calif.-based firm unveiled positive top-line results from a pair of studies evaluating RT002 for the treatment of glabellar, or frown, lines.

Kite Takeover by Gilead Lifts Biotech Stocks

Kite Takeover by Gilead Lifts Biotech Stocks

The key to dealing with this environment is to keep an open mind.

Bullish and Bearish Reversals for This Week

Bullish and Bearish Reversals for This Week

Financial names populate the bullish side.

Activist VenBio Wins Control of Immunomedics Board

Activist VenBio Wins Control of Immunomedics Board

VenBio gained four seats on Immunomedics' board of directors.

Activist Investor to Block Partnership of Immunomedics and Seattle Genetics

Activist Investor to Block Partnership of Immunomedics and Seattle Genetics

The largest shareholder of Immunomedics, VenBio, asks for an injunction against its partnership with Seattle Genetics.

The Sale of Immunomedics Hinges on This

The Sale of Immunomedics Hinges on This

Immunomedics has been for sale for quite some time, but there hasn't been any interest in it. Here's why.

Immunomedics downgradeded at Jefferies

Why Worry About the Big Picture?

There are 280 stocks hitting new highs.

What Shutdown?

This market refuses to stay down for long.

Bulls Stay on a Roll

They score yet another V-shaped bounce.